GB Meka
Stocks to watch

GILD

Compare

GILEAD SCIENCES INC · Healthcare

$149.05
▼ 1.5%Close 2026-09-30

Live intraday price

Compare with our price levels

T2161.63
T1154.73
E1141.49
E3132.27
SL128.82

Close 2026-09-30: $149.05 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 5.1% · 1 whale recently bought

1 month
▲ 2.4%
3 months
▲ 19.0%
1 year
▲ 35.6%
Analyst target
$158.65 +6.4%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$141.49 -5.1%
E2$134.79 -9.6%
E3$132.27 -11.3%
Targets
T1$154.73 3.8%
T2$161.63 8.4%
T3$168.54 13.1%
Stop-loss
SL$128.82 -13.6%
Whale cost ~$116.30 -22.0%

Risk : reward 1 : 3.5Moves ~$3.45 a day

⚖️ Positives and risks

✓ Positives (3)
  • ●1 whale bought or added last quarter
  • ●Long-term uptrend (above a rising MA200)
  • ●Most analysts rate it Buy
! Risks (2)
  • ●Company is still losing money (negative net margin)
  • ●High debt: D/E 223%

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Dickinson Andrew D · CFO

2026-09-15 · 3,000 shares @ $145.29 · pre-planned sale (10b5-1)

$435,870
Sell

Mercier Johanna · Officer

2026-09-15 · 1,600 shares @ $143.69 · pre-planned sale (10b5-1)

$229,907
Sell

Mercier Johanna · Officer

2026-09-15 · 800 shares @ $144.46 · pre-planned sale (10b5-1)

$115,566
Sell

Mercier Johanna · Officer

2026-09-15 · 600 shares @ $145.29 · pre-planned sale (10b5-1)

$87,174
Sell

O'Day Daniel Patrick · CEO · Chair · Director

2026-09-01 · 7,992 shares @ $148.36 · pre-planned sale (10b5-1)

$1M
Sell

O'Day Daniel Patrick · CEO · Chair · Director

2026-09-01 · 5,408 shares @ $149.38 · pre-planned sale (10b5-1)

$807,856
Sell

O'Day Daniel Patrick · CEO · Chair · Director

2026-09-01 · 1,600 shares @ $147.51 · pre-planned sale (10b5-1)

$236,014
Sell

WELTERS ANTHONY · Director

2026-08-26 · 6,880 shares @ $148.82 · pre-planned sale (10b5-1)

$1M
Sell

WELTERS ANTHONY · Director

2026-08-26 · 4,600 shares @ $148.82 · pre-planned sale (10b5-1)

$684,590
Sell

WELTERS ANTHONY · Director

2026-08-26 · 3,402 shares @ $148.24 · pre-planned sale (10b5-1)

$504,296
Sell

WELTERS ANTHONY · Director

2026-08-26 · 3,118 shares @ $148.31 · pre-planned sale (10b5-1)

$462,432
Sell

Bluestone Jeffrey · Director

2026-08-20 · 1,816 shares @ $144.92 · pre-planned sale (10b5-1)

$263,183
Sell

Bluestone Jeffrey · Director

2026-08-20 · 1,658 shares @ $145.73 · pre-planned sale (10b5-1)

$241,618
Sell

Bluestone Jeffrey · Director

2026-08-20 · 1,165 shares @ $143.75 · pre-planned sale (10b5-1)

$167,474
Sell

Bluestone Jeffrey · Director

2026-08-20 · 335 shares @ $146.26 · pre-planned sale (10b5-1)

$48,997

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-08-04Beat +7%

Actual EPS -$6.75 · est. -$7.25 · After close

▼ 2.6%

Day 1

+13.5%

Next 20 days

2026-05-07Beat +6%

Actual EPS $2.03 · est. $1.91 · After close

▼ 2.0%

Day 1

-2.5%

Next 20 days

2026-02-10In line +3%

Actual EPS $1.86 · est. $1.81 · After close

▲ 5.8%

Day 1

-6.8%

Next 20 days

2025-10-30Beat +16%

Actual EPS $2.47 · est. $2.14 · After close

▲ 1.1%

Day 1

+3.8%

Next 20 days

2025-08-07In line +3%

Actual EPS $2.01 · est. $1.96 · After close

▲ 8.3%

Day 1

-3.0%

Next 20 days

2025-04-24In line +2%

Actual EPS $1.81 · est. $1.78 · After close

▼ 2.8%

Day 1

+4.1%

Next 20 days

2025-02-11Beat +12%

Actual EPS $1.90 · est. $1.70 · After close

▲ 7.5%

Day 1

+9.7%

Next 20 days

2024-11-06Beat +30%

Actual EPS $2.02 · est. $1.55 · After close

▲ 6.8%

Day 1

-5.9%

Next 20 days

Listen to the earnings call or read the full report on GILD's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$187.1B
Next earnings2026-10-29
P/E (price to earnings)-
Forward P/E (on expected earnings)15.3
Revenue growth (YoY)+10.2%
Earnings growth (YoY)-
Net profit margin-10.6%
ROE-20.7%
Debt to equity (D/E)223%
Dividend yield2.17%
Analyst targets (high / low)$180.00 / $123.00
Number of analysts26
Trend and technical indicators
Trend short / mid / longUptrend ↗ · Uptrend ↗ · Uptrend ↗
RSI54
MA50 / MA200$141.98 / $134.94
Distance from MA200+10.5%
MACDNegative
1-year high / low$154.51 / $105.84
vs. S&P 500 (6 months)-9.6%
Volume vs. average0.89×